A 5-HT1A and α2-AR antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Spiroxatrine

Item No. 33415

Technical Information
Formal Name
8-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
CAS Number
1054-88-2
Synonyms
  • R-5188
Molecular Formula
C22H25N3O3
Formula Weight
Purity
≥98%
A solid
Acetontrile: Slightly soluble: 0.1-1 mg/mlDMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(NCN1C2=CC=CC=C2)C31CCN(CC4OC5=C(OC4)C=CC=C5)CC3
InChi Code
InChI=1S/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26)
InChi Key
JVGBTTIJPBFLTE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Spiroxatrine is an antagonist of the serotonin (5-HT) receptor subtype 5-HT1A (Ki = 3 nM) and α2-adrenergic receptors (α2-ARs; Kis = 28, 1.3, and 1.8 nM for α2A, α2B, and α2C, respectively).1 It is selective for these receptors over 5-HT1D (Ki = 2 µM) and 5-HT1B at 10 µM. Spiroxatrine also induces calcium mobilization in CHO cells expressing the human nociception opioid peptide (NOP) receptor (EC50 = 323 nM).2 It inhibits decreases in mean arterial pressure induced by urapidil in anesthetized normotensive cats when administered at doses of 3 or 10 nmol/kg.3 Spiroxatrine (2.5 and 5 mg/kg) induces catalepsy and catatonia in rats.4 It enhances reductions in ethanol intake induced by fluoxetine in alcohol-preferring rats.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sorbi, C., Tait, A., Battisti, U.M., et alSpiroxatrine derivatives towards 5-HT1A receptor selectivity. Pharmacol. Rep. 72(2), 427-434 (2020).

    2. Corrado, S., Battisti, U.M., Sorbi, C., et alSynthesis and structure-activity relationships of triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands. Chem. Biol. Drug Des. 86(4), 447-458 (2015).

    3. Kolassa, N., Beller, K.D., and Sanders, K.H. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil. Am. J. Cardiol. 64(7), 7D-10D (1989).

    4. Costall, B., and Naylor, R.J. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 34(3), 233-241 (1974).

    5. McBride, W.J., Murphy, J.M., Lumeng, L., et alSpiroxatrine augments fluoxetine-induced reduction of ethanol intake by the P line of rats. Pharmacol. Biochem. Behav. 34(2), 381-386 (1989).